comparemela.com
Home
Live Updates
Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties : comparemela.com
Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties
Annamycin demonstrated to be a more potent inhibitor of topoisomerase II-alpha and II-beta while remaining inactive against established cardiomyocyte cultures...
Related Keywords
United States ,
San Diego ,
California ,
University Of Texas ,
Texas ,
Houston ,
American ,
Jenene Thomas ,
Walter Klemp ,
Preliposomal Annamycin Lyophilizate ,
Facebook ,
Twitter ,
Trademark Office ,
Properties Of Annamycin ,
Securities Exchange ,
American Association For Cancer Research ,
Linkedin ,
Moleculin Biotech Inc ,
Exchange Commission ,
Nasdaq ,
Moleculin Biotech ,
American Association ,
Cancer Research ,
Annual Meeting ,
Non Cardiotoxic Properties ,
Clinically Evaluated Anthracycline ,
Potent Topoisomerase ,
Breaking Research ,
Molecular Therapeutics ,
Chief Executive Officer ,
Data Highlights ,
United States Patent ,
Preliposomal Annamycin ,
System Board ,
Transcription Modulator ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.